Prosecuting Excessive Pricing of Pharmaceuticals under Competition Law : Evolutionary Development
Year of publication: |
2023
|
---|---|
Authors: | Abbott, Frederick M. |
Publisher: |
[S.l.] : SSRN |
Subject: | Wettbewerbsrecht | Competition law | Arzneimittel | Pharmaceuticals | EU-Staaten | EU countries | Theorie | Theory | Preismanagement | Pricing strategy |
Extent: | 1 Online-Ressource (46 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments January 7, 2023 erstellt |
Other identifiers: | 10.2139/ssrn.4320036 [DOI] |
Classification: | I18 - Government Policy; Regulation; Public Health ; K21 - Antitrust Law ; L41 - Monopolization; Horizontal Anticompetitive Practices ; O34 - Intellectual Property Rights: National and International Issues ; o36 |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Excessive Pharmaceutical Prices and Competition Law : Doctrinal Development to Protect Public Health
Abbott, Frederick M., (2017)
-
Geradin, Damien, (2018)
-
Pharmaceutical Antitrust Enforcement in the United States and Chile
Carrier, Michael A., (2021)
- More ...
-
Intellectual property rights in world trade
Abbott, Frederick M.,
-
Abbott, Frederick M.,
-
Abbott, Frederick M.,
- More ...